Antihypertensive effects of sympathomimetic amines.
D000588:Amines / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003864:Depression, Chemical; D004285:Dogs; D004809:Ephedrine / Q000494:pharmacology; D005260:Female; D005277:Fenfluramine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006977:Hypertension, Renal / Q000503:physiopathology; D007556:Isoxsuprine / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D010645:Phentermine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D013997:Time Factors
D000588:Amines; D013566:Sympathomimetics; D010656:Phenylephrine; D005277:Fenfluramine; D008694:Methamphetamine; D008464:Mecamylamine; D008680:Metaraminol; D010645:Phentermine; D000661:Amphetamine; D004809:Ephedrine; D008729:Methoxamine; D007556:Isoxsuprine; D010633:Phenmetrazine